ALSF is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. The RUNX1 Research Program (runx1.com) is dedicated to advancing areas of research of particular importance to families affected by familial platelet disorders (FPDs) leading to acute myeloid leukemia (AML) due to germline RUNX1 mutations with the ultimate goal of developing effective therapies to prevent the onset of AML.
ALSF and RUNX1 Research Program have partnered to raise awareness and accelerate research around familial RUNX1 disorders:
RUNX1 Early Career Investigator Grant: Up to $180,000 over three years
To promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder. We believe that providing capital to early career investigators not only injects funding into where it is needed most, but also cultivates a new cohort of investigators who will be invested in an area of research that historically has had limited attention.
The Program is viewed as a long-term endeavor of collaboration and data sharing. We are especially interested in innovative and cross-disciplinary approaches to developing effective therapies.
Please complete a one-time New User registration. You will create your institution account, contact record and portal username/password. An email confirmation will be sent to verify your email address, completing your registration. Then login to access the grant application. NOTE: IE browser is incompatible with the online system; please use Chrome or Firefox for best results!